NEW YORK (GenomeWeb News) – Akesogen, a Norcross, Ga.-based genomic and biorepository services firm, and London Genetics International today announced that they will collaborate on offering pharmacogentic services to the biopharmaceutical industry.
Among the services provided by the firms will be biomarker and assay development. Financial and other terms were not disclosed.
"Our expertise in pharmacogenetic strategy development combined with a professional genomics services company that operates to CLIA standards will make this strategic alliance beneficial to both companies as it will increase our scope of possible services into the Americas with highly qualified and service oriented scientists," Elizabeth Foot, VP of personalised medicine and nutrition for London Genetics, said in a statement.